SeaStar Medical Holding (ICUCW) Stock Analysis

What SeaStar Medical Holding does

Based in Denver, Colorado, SeaStar Medical Holding Corporation operates as a medical device company. Its primary mission is to develop innovative therapies and services designed to combat hyperinflammation and cytokine storm, particularly in critically ill individuals. The company specializes in advancing and bringing to market extracorporeal treatments. These therapies are engineered to specifically target the immune "effector cells" that fuel widespread systemic inflammation, which is known to cause direct tissue damage and unleash a cascade of pro-inflammatory cytokines, leading to dysregulated immune responses. SeaStar Medical's product pipeline extends across diverse therapeutic domains. These include both pediatric and adult acute kidney injury, particularly when patients are undergoing continuous renal replacement therapy (CRRT); cardiorenal syndrome observed in cases of congestive heart failure, whether or not an LVAD is present; myocardial stunning associated with end-stage renal disease; and hepatorenal syndrome.

Key metrics

ETFs linked to ICUCW

Broad-market and Healthcare sector ETFs an investor holding SeaStar Medical Holding is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ICUCW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for SeaStar Medical Holding?

SeaStar Medical Holding trades under the ticker ICUCW on NASDAQ.

Which exchange is ICUCW listed on?

ICUCW is listed on NASDAQ.

What sector does SeaStar Medical Holding operate in?

SeaStar Medical Holding is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ICUCW in a portfolio?

PortView shows ICUCW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.